Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 5Buscopan
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2019 Revenue in Millions : 206
2018 Revenue in Millions : 211
Growth (%) : -3
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 214
2019 Revenue in Millions : 229
Growth (%) : -6
Main Therapeutic Indication : Anti-Inflammatory
Currency : USD
2018 Revenue in Millions : 219
2017 Revenue in Millions : 216
Growth (%) : 2%
Main Therapeutic Indication : Anti-Inflammatory
Currency : USD
2016 Revenue in Millions : 250
2015 Revenue in Millions : 236
Growth (%) : 6
Main Therapeutic Indication : OTC
Currency : USD
2014 Revenue in Millions : 8%
2013 Revenue in Millions :
Growth (%) :
LOOKING FOR A SUPPLIER?